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Introduction
Disease of the motor unit is common in children. These neuromuscular diseases may 
be genetically determined, congenital or acquired, acute or chronic, and progressive 
or static. (1)
Neuromuscular disorders have limited clinical expression with considerable overlap 
of symptoms and signs. (2)
Because of availability of new specific therapies for many diseases and for genetic 
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Abstract
Objective 
Muscle biopsy is a very important diagnostic test in the investigation of a 
child with suspected neuromuscular disorder. The goal of this study was to 
review and evaluate pediatric muscle biopsies during a 2-year period with 
focus on histopathology diagnosis and correlations with other paraclinic 
studies. 
Materials & Methods
We investigated 100 muscle biopsies belonging to patients with clinical 
impression of neuromuscular disorder. These patients have been visited 
consecutively by pediatric neurologists during 2010 to 2012. Samples were 
investigated by standard enzyme histochemical and immunohistochemical 
techniques. 
Result
Sixty-nine (69%) males and 39 (39%) females with a mean age of 5.7 years 
were evaluated. Major pathologic diagnoses were Muscular dystrophy 
(48 cases), Neurogenic atrophy (18 cases), nonspecific myopathic atrophy 
(12cases), congenital myopathy (6 cases), storage myopathies (4 cases) and 
in 6 cases there was no specific histochemical pathologic finding. EMG was 
abnormal in 79 cases. Degree of correlation between EMG and biopsy result 
was significant in children ≥ 2 years of age.
Conclusion
This study confirms the high diagnostic yields of muscle biopsy 
especially only if standard and new techniques such as enzyme study and 
immunohistochemistry are implemented. Also, we report 11 cases of Merosin 
negative congenital muscular dystrophy. This is the largest documented case 
series of Merosin deficient congenital muscular dystrophy reported from Iran.
Keywords: Muscle biopsy; Congenital myopathy; Muscular dystrophy; 
Merosin; EMG
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and prognostic implications, precise diagnosis is very 
important. (1)
Definitive diagnosis depends on the proper applications 
of laboratory techniques. (2) The procedures used most, 
are serum myogenic enzymes, electro myography 
(EMG), and muscle biopsy. (2)
Muscle biopsy has become the most essential diagnostic 
procedure in evaluating a child with neuromuscular 
disease.
To date, there is no comprehensive study about 
prevalence of muscular disorders among Iranian 
children.
The present study was performed to evaluate actual 
status of neuromuscular disorders in our patients who 
were candidate for muscle biopsy.
Materials & Methods
We have retrospectively reviewed the medical records 
concerning muscle biopsies belong to 100 children 
with clinical impression of neuromuscular disorder 
referred for muscle biopsy in Mofid and Toos hospitals 
from September 2010 to September 2012.
A pediatric neurologist initially visited all 100 children 
aged between 4 months to 15 years old.
Based on medical history and physical examination, 
myogenic enzymes and EMG study they were candidate 
for muscle biopsy.
All data, including age, sex, EMG reports, myogenic 
enzymes, family history and consanguinity of parents 
were collected.
All muscle samples delivered immediately to 
myopathology lab in fresh state and were frozen in 
isopentane cooled in liquid nitrogen and a standard 
panel of histochemical stains (H&E, trichrome 
Gomori, Congo red, PAS, Oil red O, NADH-TR, SDH, 
Cox, Cox+SDH and ATPase x3) were performed for 
all the samples. Immunohistochemical study was 
performed for 43 patients composed of antibodies 
against Dystrophin (DYS1,2,3), alpha and gamma 
Sarcoglycans, Dysferlin, Merosin and also beta-
Spectrin as a positive control. 
The collected data were analyzed with statistical 
package for the social sciences (SPSS) soft ware (version 
18), Also, chi-Square test or Fisher’s exact test were 
performed for categorical variables.
Results
In this study100 patients (61% males and 39% females) 
were included. The patients at the time of muscle 
biopsy aged between 4 months to 15 years (Figure1). 
The results indicated that only 20 cases had family 
history of muscle diseases (20% positive family history), 
fifty-eight patients were result of a consanguinity 
marriage.
The diagnostic results were as follow: muscular 
dystrophy was reported in 48 cases, out of which 10 
were Duchenne muscular dystrophy, 13 were reported 
as Sarcoglycanopathy, among them 2 cases were 
suggested as alpha, 5 as gamma and 6 cases were 
suggested as beta sarcoglycanopathy. One of the 
dystrophic patients suffered from Dysferlinopathy 
and in 11 cases Merosin negative congenital muscular 
dystrophy was confirmed. IHC study was normal in 8 
cases of muscular dystrophy and in 5 cases the data on 
IHC study is not available. 
Neurogenic atrophy was diagnosed in 18 cases, among 
them 14 cases were clinically or genetically confirmed 
as spinal muscular atrophy. 
Metabolic myopathies were diagnosed in 4 cases 
composed of 2 cases of juvenile Pompe and 2 cases 
of lipid storage myopathy. Congenital myopathy was 
reported in 6 cases out of which 4 were congenital 
myopathy with core lesions and 2 were Nemaline 
myopathy. One case of dermatomyositis was diagnosed. 
Selective type 2 fibers atrophy was seen in 5 cases and 
in 6 cases no specific histochemical pathologic finding 
was seen (Table 1).
Creatine Kinase was within abnormal limit in 66 cases 
and EMG was abnormal (myopathic or neurogenic 
patterns) in 79 cases.
There is a correlation in 50 cases (50%) of patients 
between abnormal CK level, EMG and muscle biopsy 
result as any myopathic finding (Figure 2).
In spite of positive correlation between EMG and CK 
level in cases of myopathic results, biopsy results from 
10 cases didn’t demonstrate myopathy (Figure 2).
Degree of correlation between biopsy and EMG in 
patients less than 2 years of age was 18/3%, while in 
children more than 2 years of age was (82%), the 
difference between the 2 groups is statistically significant 
(Pvalue=0.012) (Table 2).
Evaluation of One Hundred Pediatric Muscle Biopsies During A 2-Year Period in Mofid Children And Toos Hospitals
19Iran J Child Neurology Vol 7 No 2 2013 Spring
congenital muscular dystrophy in Iranian population 
but maybe it is due to our method of patient selection. 
Our study presents the largest documented case series 
of Merosin deficient congenital muscular dystrophy 
reported from Iran.
We collected 6 cases with no specific histopathologic 
finding. The paucity of no specific findings in our 
muscle biopsy specimens may be due to orthodox 
selection of candidates for muscle biopsy.
Degree of correlation between biopsy and EMG in 
patients < 2 years of age was 18/3%, while in children 
≥ 2 years of age was 82%, the difference between the 
two groups is statistically significant (p value=0.012). 
These data show that EMG results are not reliable for 
children less than 2 years of age. This is in concordance 
with another study which shows EMG detection rate of 
myopathic motor unit potentials at a young age as low, 
improving in children over 2 years of age (6).
This study confirms the high diagnostic yields of muscle 
biopsy especially only if standard and new techniques 
such as enzymes study and immunohistochemistry are 
implemented. 
Discussion
In this study we do not present the frequency of 
neuromuscular disorders in Iranian children as we did 
not study 100 patients entering the neuromuscular clinic 
and we just studied 100 biopsy samples from patients 
who were candidates for muscle biopsy and this data is 
not representative of prevalence or frequency of muscle 
diseases in Iranian children.
Based on the present data muscular dystrophies were 
the most common type of neuromuscular disorders 
(48%) in our study like other studies (3, 4), but in 
one study that was taken in India; SMA was the most 
common disorders (5).
The main reason is patient selection method; as many 
Iranian neurologists order “molecular genetic test“ 
as the first-line work up in cases suspected of having 
SMA. 
We found 11cases (11%) of Merosin negative congenital 
muscular dystrophy in our study, while the incidence of 
this disorder was approximately 10 times more than the 
study reported from India (5). We believe that this is not 
because of the higher prevalence of Merosin negative 
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Table1. Muscle Biopsy Results
Frequency Percent
Neurogenic atrophy 18 18.o
Sarcoglycanopathy 13 13.0
Nonspecific myopathic atrophy 12 12.0
Merosin Negative congenital muscular atrophy 11 11.0
Dystrophinopathy 10 10.0
Dystrophy with normal IHC 8 8.0
NO Specific histochemical pathologic finding 6 6.o
Dystrophy without IHC study 5 5.0
Selective type 2 fibers atrophy 5 5.o
Congenital myopathy with cores 4 4.o
Lipid storage myopathy 2 2.0
Glycogen storage myopathy 2 2.o
Nemaline Myaopathy 2 2.o
Dermatomyositis 1 1.o
Dysferlinopathy 1 1.o
Total 100 100
Table 2. Comparison of Muscle Biopsy with EMG based on Age Groups
Age (yr)
EMG 
Total
Negative Positive
2> 9 (50%) 15 (18.3%) 24 (24%)
2≤ 9 (50%) 67 (81.7%) 76 (76%)
18 82 100
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6. Rabie M, Jossiphov J, Nevo Y. Electromyography 
accuracy compared to muscle biopsy in childhood. J 
Child Neurol 2007 jul; 22(7):803.8.
Fig 2. Correlation among CK and BIOPSY and EMG RESULTS, EMG+: myopathic or neurogenic patterns, 
EMG- : normal patterns, M.Biopsy+: any kinds of myopathic results in muscle biopsy,M.Biopsy - :Muscle 
biopsy with no specific pathologic finding
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